Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Ethan P Oxley und 22 weiteren Autor:innen. Beteiligte Einrichtung: Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia. Hauptthemen laut MEDLINE: B7-H1 Antigen, B7-1 Antigen, Abatacept, T-Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F. Hoffmann-La Roche, National Health and Medical Research Council, John T Reid Charitable Trusts.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Centre for Blood Diseases, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia.
- Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia; Department of Medical Biology, The University of Melbourne, Royal Parade, Parkville, VIC 3052, Australia.
- Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
- Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
- Department of Immunology and Pathology, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia.
- Department of Immunology and Pathology, Monash University, 99 Commercial Road, Melbourne, VIC 3004, Australia; Department of Allergy, Immunology & Respiratory Medicine, Monash University, Melbourne, VIC 3004, Australia.
Förderung
- F. Hoffmann-La Roche
- National Health and Medical Research Council
- John T Reid Charitable Trusts
- Bristol-Myers Squibb Company
- Department of Health, State Government of Victoria
Zitieren
APA
Oxley, E. P., Kershaw, N. J., Louis, C., Goodall, K. J., Garwood, M. M., Jee Ho, S. M., Voo, V. T. F., Park, H. Y., Iaria, J., Wong, L. L. L., Lebenbaum, A. G., Wiranata, S., Pang, E. S., Edwards, E. S. J., D'Silva, D. B., Hansen, J., van Zelm, M. C., O'Keeffe, M., Hogarth, P. M., …, & Dickins, R. A. (2024). Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114834
Vancouver
Oxley EP, Kershaw NJ, Louis C, Goodall KJ, Garwood MM, Jee Ho SM, et al. Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114834
BibTeX
@article{Oxley2024,
author = {Oxley, Ethan P and Kershaw, Nadia J and Louis, Cynthia and Goodall, Katharine J and Garwood, Maximilian M and Jee Ho, Skye Min and Voo, Veronica T F and Park, Hae-Young and Iaria, Josephine and Wong, Lilian L L and Lebenbaum, Ariel G and Wiranata, Stephanie and Pang, Ee Shan and Edwards, Emily S J and D'Silva, Damian B and Hansen, Jacinta and van Zelm, Menno C and O'Keeffe, Meredith and Hogarth, P Mark and Haynes, Nicole M and Huntington, Nicholas D and Wicks, Ian P and Dickins, Ross A},
title = {Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activity},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114834}
}
EUVIMED